We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

SARCOMA BIOPSY MARKET ANALYSIS

Sarcoma Biopsy Market, by Product Type (Reusable Device and Disposable Devices), by End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

  • Published In : May 2020
  • Code : CMI3819
  • Pages :151
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Biopsy is a procedure of removing of a small amount of tissue for examination under a microscope. Imaging tests may suggest the diagnosis of sarcoma, but biopsy is performed to confirm the diagnosis and to find out the type of sarcoma. Several types of biopsies are used to diagnose sarcomas and most biopsies are needle biopsies, in which needle is used to access the suspicious tissue of sarcoma.

The global sarcoma biopsy market was valued at US$ 197.94  million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).

Fig1. Global Sarcoma Biopsy Market Share (%) Analysis, By Product Type, 2019

SARCOMA BIOPSY MARKET

To learn more about this report, request sample copy

Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.

Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.

There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.

Global Sarcoma Biopsy Market– Regional Analysis

North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.

Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.

Fig.2 Global Sarcoma Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

SARCOMA BIOPSY MARKET

To learn more about this report, request sample copy

Global Sarcoma Biopsy Market- Competitive Landscape

Key players operating in the global sarcoma biopsy market include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab

Share

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The CAGR of the global sarcoma biopsy market is expected to be 2.8% during the forecast period (2020-2027).

The value of global market for global sarcoma biopsy market was US$ 192.55 million in 2019.

The prominent players of global sarcoma biopsy market across the globe include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab

The global sarcoma biopsy market is expected to reach US $ 247.47 million by 2027.

North America is major region for global sarcoma biopsy market.

Increasing prevalence of bone cancer, increasing prevalence of osteosarcoma and technology advancement in the field of biopsy
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Select a License Type





Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.